Meeting
2015 Genitourinary Cancers Symposium
An impact of pelvic MRI (PMRI) to radiotherapy (RT) target volumes definition in prostate cancer patients (pts).
Authors
Keren Rouvinov
Soroka Medical Center, Beersheba, Israel
Keren Rouvinov , Wilmosh Mermershtain , Olga Beloshicki , Shmuel Ariad , Konstantin Lavrenkov
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 78)
DOI
10.1200/jco.2015.33.7_suppl.78
Abstract #
78
Poster Bd #
D19
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
First Author: Michael Wang
Poster
2016 Genitourinary Cancers Symposium
A treatment planning comparison of proton therapy and intensity-modulated radiotherapy (IMRT) for prostate cancer using the normal tissue complication probability (NTCP).
First Author: Benjamin Walker Fischer-Valuck
Poster
2015 Genitourinary Cancers Symposium
Phase I trial of weekly cabazitaxel with concurrent intensity-modulated radiation therapy (IMRT) and androgen deprivation therapy (ADT) for the treatment of high-risk prostate cancer (PCa).
First Author: Jianqing Lin
Poster
2015 Genitourinary Cancers Symposium
Prospective phase 1 study assessing feasibility of IMRT and IGART to deliver simultaneous integrated high-dose tumor boost (up to 70 Gy) for the radical treatment of localized muscle-invasive bladder cancer.
First Author: Shaista Hafeez